Visual Proteomics Imaging
The Chan Zuckerberg Initiative (CZI) invites applications for challenge grants in the field of Visual Proteomics. This Request for Applications (RFA) aims to advance technology directed at the goal of obtaining near-atomic resolution readouts inside the cell. CZI seeks to support 2.5-year challenge grants in the field of visual proteomics. The ability to view protein molecules in cells and monitor changes in their structure, quantity, distribution, and interactions is key to understanding what causes diseases and finding treatments and cures. This grant program will advance technology development for the field of visual proteomics and aim to obtain near-atomic resolution readouts inside the cell. The funding mechanism will be targeted investments in the form of challenge grants with specified proof-of-concept milestones.
Applications Due: February 17, 2021 by 5:00 pm Pacific Time
Phillipe Foundation France/US Medical Research Exchange
The Philippe Foundation grants are designed to encourage, assist, aid and support scientific and medical activities and research by giving grants to doctors and scientists (post-graduates) interested in exchange programs between France and the United States, specifically in medical laboratories. The grants are designed to encourage and facilitate Franco-American exchanges but cannot provide the primary source of support.
The Philippe Foundation will only consider candidates who have completed a PhD in Science. For medical doctors, this requirement may be waived, but they should have a significant list of publications.
The host lab has to be focused on medical research.
Will only consider those who have been staying in the host country for less than 2 years.
The grantee is required to provide the Philippe Foundation a research report. This report and the applicant's list of latest publications (published and in process) are due upon completion of your exchange program, within 3 months of the return from host country.
Go to Applications page to download necessary documents
Application Deadline for March Session: February 28, 2021
All Level Investigators
Nurses Innovate QuickFire Challenge on Mental Health
The COVID-19 pandemic has focused a spotlight on nurses and their impact like never before, where the world is seeing nurses in action as innovative leaders who possess the resiliency and resourcefulness to navigate health emergencies and provide support to patients and fellow frontline health workers alike. Johnson & Johnson is proud to announce the Sixth QuickFire Challenge by inviting nurses and nursing students worldwide to submit their nurse-led novel concepts, education programs, protocols, prevention or treatment approaches, screening tools, and consumer product ideas with the power to potentially transform mental health care and well-being for their fellow healthcare professionals or the patients they serve amid the current pandemic environment and beyond.
The nurse innovators with the best idea(s) will receive up to $100,000 in grant funding and access to mentoring from experts across the Johnson & Johnson Family of Companies to help bring their ideas to life. Ideas may include potential solutions for practice in any setting, including inpatient, outpatient, education, private practice, community, military and VA settings and can address health and wellness promotion, prevention of mental health conditions, and care & treatment considerations for persons with psychiatric and/or substance use disorders. Example focus areas include:
- Mental health conditions including trauma, depression, PTSD, etc.
- The impact of health disparities/health inequities on mental health needs
- Access to care and treatment for those with mental health and/or substance use conditions
- Remote care delivery opportunities such as telehealth.
Applications Due: January 15, 2021
All Level Investigators
DIVERSITY IN CLINICAL TRIALS CAREER DEVELOPMENT PROGRAM
The BMSF Diversity In Clinical Trials Career Development Program (DCTCDP) is a 2-year program designed to support the career development of early stage investigator (as defined by NIH) physicians underrepresented in medicine, or, physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring.
The DCTCDP offers a comprehensive and integrated approach to increasing diversity in clinical trials through workforce development and clinical trial site development in underserved communities where underrepresented patients receive care. The program will support established clinical trials sites/centers of excellence to engage with nearby community and safety net healthcare delivery institutions to enhance their clinical trial capacity and to collaborate on research, and it will support the transition of research naïve sites to fully functional clinical trial sites through an infrastructure investment fund.
Letter of Intent & Invited Application Process Opens: Jan 4, 2021
Full Application due: July 2, 2021
Informational Webinar #1:
Dec. 16, 2020 Time: 1-2 pm EST
Informational Webinar #2:
Date: Dec. 21, 2020 Time: 3-4 pm EST
See more information on the Information Sheet.
Early Stage Investigators
The Damon Runyon Cancer Research Foundation is inviting applications for its Clinical Investigator Award. The award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.
The Clinical Investigator Award responds to three recognized realities:
- Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
- The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
- The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
Application deadline: February 1, 2021
Early Stage Investigators
Doris Duke Charitable Foundation Physician Scientist Fellowship
The Physician Scientist Fellowship (PSF) award aims to support research during the final years of subspecialty fellowship and aid in the transition into an academic faculty appointment. The specific goals of the PSF program are to:
1) support physician scientists in subspecialty fellowship to conduct an outstanding clinical research project
2) ensure research time protection to enable development of research skills; and
3) facilitate strong mentorship relations.
Grants of up to $220,000 over two years ($100,000 direct cost and $10,000 indirect costs per year) will be awarded to physician scientists (MD, MD/PhD, DO, or foreign equivalent) in subspecialty fellowship training working at US medical institutions to support two years of clinical research that will strengthen their careers as biomedical investigators.
See full announcement for eligibility criteria and full award information.
Applications due: January 5, 2021, 3 pm ET
PostDoctoral/Early Stage Investigators (physician scientists)
Collaboration and Community Engagement
James Roosevelt, Jr., Leadership Fund
This grant program is designed to support multiple community stakeholders and sectors working toward a common goal. Support for this work considers current or new activities that directly or indirectly lead to age-friendly communities and address barriers in the most vulnerable communities.
The Foundation seeks to fund efforts that:
- Convene, support and expand collaborations that lead to systems/service access and improvement on a larger geographic scale (multiple counties, statewide, or New England-wide) or across multiple sectors
View the information session webinar on the Foundation website. Only one LOI per institution is allowed. If you are planning on submitting a LOI, please contact Melodi Moore to learn how the limited submission will work.
Letters of Intent due: January 22, 2021 by 4 pm.
John H. Rippey Grant for Expedited Research
The Impact of Laboratory Testing for SARS-CoV-2 on Quality and Patient Safety
This grant honors the memory of John H. Rippey, MD, an advocate of the CAP who was devoted to improving laboratory quality assurance. The CAP Foundation is repositioning the grant to provide funding for investigation of the impact of COVID-19-related tests, principally nucleic acid amplification and serologic methods, on patient outcomes, including studies related to test accuracy, timeliness, and result communication. Applicants must demonstrate how their projects support quality assurance, quality and/or process improvements in pathology, or patient safety, with the result of improved patient care.
Applicants must be CAP members
Applications for funding due: Monday, January 11, 2021, 5 pm Central
FDA COVID-19 & Other Quantitative Systems Pharmacology Fellowship
A research opportunity is available in the Office of Translational Sciences Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
This project will be developing quantitative systems pharmacology models that combine pharmacokinetics, pharmacodynamics, and underlying biology to study the efficacy and safety of drugs for various diseases or conditions. Example areas of modeling are: models that combine viral life cycle, human immune responses, and drug actions to predict efficacious drug combinations to treat COVID-19, modeling the relationship between opioid-receptor interactions and respiratory depression.
Under the guidance of a mentor, the participant will learn to develop individual components of mechanistic models, such as pharmacokinetic models, pharmacodynamic models, systems biology models, and combine them into a prediction framework to evaluate drug efficacy/safety in various areas.
Application Deadline: March 31, 2021 3:00:00 PM Eastern
Postdoctoral Research Opportunity in Microbiology
A microbiology postdoctoral research opportunity is available with the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS), National Animal Disease Center (NADC), Food Safety and Enteric Pathogens Research Unit (FSEPRU) located in Ames, Iowa.
The selected participant will be conducting research to identify novel mechanisms in the interactions of the human foodborne pathogen Salmonella with the host (swine and poultry) and the host microbiota to develop targeted interventions. This research program involves multiple projects focusing on the identification of alternatives to antibiotics in food animals (such as vaccines, biotherapeutics, feed additives, etc.) as well as the investigation of antimicrobial resistance mechanisms in multi-drug resistant (MDR) Salmonella serovars.
The selected participant will collaborate with a team of microbiologists, immunologists, bioinformaticians, and veterinarians to achieve the learning objectives: investigate host-microbe interactions for the discovery of antimicrobial resistance mechanisms and antibiotic alternatives that will benefit animal health and food safety.
Application Deadline: May 18, 2021 3:00PM Eastern
Emerging Research Grant
The Hearing Health Foundation is accepting applications for the Emerging Research Grant. This opportunity is open to those who:
- hold an Au.D., M.D., Ph.D., or equivalent degree, and
- hold an appointment at a non-profit educational, governmental or other research institution located in the United States. Appointments include faculty, postdoctoral fellow, or clinical/research fellow. Current medical residents in otolaryngology may also apply. Other medical residents and Ph.D. students are not eligible.
Applications require the approval of an authorized signatory at your institution. Ensure you leave enough time for this step to be completed. Please read the full instructions for more details.
Application deadline: February 26, 2021, by 11:59PM EST
Multi-Level Investigators (no students)
Lupus Innovation Award
Formerly known as the Novel Research Grant, this award provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Both early career and established investigators new to lupus with highly innovative ideas are encouraged to apply. Early stage investigators are eligible for an additional third year of funding contingent upon successful completion of the original grant.
Click here for the Request for Applications
Letter of Intent due: February 16, 2021
NASA Space Physiology Research Grant
Through the generosity of the National Aeronautics and Space Administration (NASA), money is available for research grants in the area of exercise, weightlessness and musculoskeletal physiology. Doctoral students enrolled in full-time programs are eligible to apply. Grants can range up to $5,306 and are available for a one-year period. Only U.S. citizens or permanent residents are eligible to apply.
Applicants for student research grants must have graduate student status during the term of the grant to be considered for funding. Applicants must be current members of ACSM at the time of submitting an application. Grants are open to all ACSM members, including international members. However, the NASA initiative is open to U.S. citizens or permanent residents working in U.S. universities only.
Application Deadline: January 22, 2021, 11:59 p.m. EST
Pre-Doctoral Students Only
Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research
This program was developed to address the current concerns about an adequate funding base for postdoctoral fellows (MD, MD/PhD and PhD) who specifically direct their research towards basic aging mechanisms and/or translational findings that have direct benefits to human aging. Postdoctoral fellows at all levels of training are eligible. Up to ten one-year fellowships of $60,000 will be awarded in 2021.
Letter of Intent Due: January 25, 2021
Postdoctoral Investigators Only
Postdoctoral Research Fellowships
AES Postdoctoral Research Fellowships support postdoctoral trainees conducting research into the causes, treatment, and consequences of epilepsy under the guidance of a mentor with expertise in epilepsy research. Proposals are welcomed across the spectrum of basic, translational, and clinical epilepsy research.
The fellowship award offers up to $50,000 for stipend and travel support to the AES Annual Meeting for one year, as well as a one-year AES membership. The number of awards granted each year is contingent upon available funds.
Applications Due: January 13, 2021
Postdoctoral Investigators Only
Research Professor Grants
Open to investigators who have been a full professor for 15 years or less and made seminal contributions that have changed the direction of cancer care research and who expect to continue to provide leadership in their research area. $80K/year for a 5-year term; renewable
Letter of Intent Due: February 1, 2021
Mid Career Investigators
Research Scholar Grants (RSG)**
UPDATED - Investigators within the first 8 years of an initial independent research career or faculty appointment; eligibility extends to 10 years for clinician scientists who remain active in clinical care. Up to 4 years at $165K/year (direct costs), plus 20% allowable indirect costs
Application Deadline: April 1, 2021
New/Early Stage Investigators
Postdoctoral Fellowships (PF)**
Investigators who are US citizens or permanent residents and within 3 years of receiving a doctoral degree NOTE: 1-year fellowships have been eliminated; resubmissions are grandfathered and will be accepted. Progressive stipends up to 3 years, plus an annual $4K fellowship allowance and $1,500 travel allowance in the final year. See improvements to parental leave!
Application Deadline: April 1, 2021
Clinician Scientist Development Grant (CSDG)**
Licensed clinicians who are US citizens or permanent residents and are within the first 6 years of their initial faculty appointment, who have an active role in patient care. $135K direct costs, plus 8% allowable indirect costs per year for 3 to 5 years.
Application Deadline: April 1, 2021
New/Early Stage Clinical Investigators Only
Health Equity Research in Cancer Control and Prevention
This opportunity identifies research addressing cancer health equity (see policies for the ACS definition) and health disparities as a priority within the Cancer Prevention and Control Research Program. Applications using one of the starred ** mechanisms will be accepted; unless specified otherwise, eligibility is unchanged.
Reducing Inequities in Cancer Outcomes through Community-Based Interventions on Social Determinants of Health (RFA-DP-21-003)
The purpose of this forecasted opportunity is to conduct evaluation research to build an evidence base of innovative, community-based interventions across multiple social determinants of health to reduce racial and ethnic disparities in cancer outcomes. The purpose will be achieved through three (3) components.
Applicants may apply for one Component of funding (Component A, or Component B, or Component C).
- Component A: Primary Cancer Prevention – to conduct evaluation research on an innovative, multi-sector intervention to reduce cancer risk in one or more racial or ethnic minority populations who experience disproportionate exposure to cancer risk factors. This research will examine the implementation, impact, and causal mechanisms of the intervention’s effect to reduce cancer risk at the population level.
- Component B: Cancer Screening – to conduct evaluation research on an innovative, multi-sector intervention to reduce inequities in the receipt of appropriate screening services (on-time initial screening, routine re-screening at recommended intervals, and appropriate follow-up after inconclusive/incomplete screening) among one or more racial or ethnic minority populations who experience disparities in cancer screening. This research will generate knowledge about the implementation, impact, and causal mechanisms of the intervention’s effect on cancer screening outcomes.
- Component C: Health and Wellbeing of Cancer Survivors – to conduct evaluation research on an innovative, multi-sector intervention to address barriers to health and well-being among cancer survivors from one or more racial or ethnic minority populations who experience disparities in health outcomes after a cancer diagnosis. This research will generate knowledge about the implementation, impact, and causal mechanisms of the intervention’s effect on the health and wellbeing of cancer survivors.
Application Deadline: 02/10/2021
Preventing Violence Affecting Young Lives
FORECASTED OPPORTUNITY - Estimated Post Date: March 8, 2021
The purpose of this funding is to address all forms of violence impacting children and youth in high burden communities by implementing prevention approaches at the outer levels of the social-ecological model (SEM). Preventing Violence Affecting Young Lives (PREVAYL) requires recipients to
1) implement community and societal level strategies and approaches that address all forms of violence impacting children and youth,
2) develop and/or enhance a jurisdictional violence prevention strategic plan,
3) develop and implement an evaluation plan,
4) develop a sustainability plan, and
5) participate in a multi-sector collaborative entity.
Applicants must demonstrate a strong understanding of the public health approach to violence prevention and have experience implementing youth violence prevention strategies. Component I – Implementation of community and societal level strategies, and expansion of Dating Matters
Early-Career Research Fellowship - Human Health & Community Resilience Track
The Early Career Research Fellowship supports emerging scientific leaders as they take risks on research ideas not yet tested, pursue unique collaborations, and build a network of colleagues who share their interest in improving offshore energy system safety and the well-being of coastal communities and ecosystems.
The Human Health and Community Resilience track aligns with one of Gulf Research Program’s five program areas, and narrows the focus of the fellowship to support the most relevant research to the goals and objectives of the Board on Gulf Health and Resilience.
For the 2021-2023 Application Cycle, the Human Health and Community Resilience track goal focuses on contributing to the advancement of health equity in the Gulf of Mexico region or Alaska by considering the social determinants of health.
Application Deadline: January 13, 2021
New/Early Stage Investigators
Postdoctoral Enrichment Program
The Postdoctoral Enrichment Program (PDEP) provides a total of $60,000 over three years to support the career development activities for underrepresented minority postdoctoral fellows in a degree-granting institution in the United States or Canada whose training and professional development are guided by mentors committed to helping them advance to stellar careers in biomedical or medical research.
Applicants should have no more than 36 months of postdoctoral research experience at the time of application and should not be more than five years from their Ph.D. Applicants must be citizens of the United States or Canada at the time of the application deadline.
Application Due: January 14, 2021